Milestone Scientific (MLSS) Reports Q2 Loss of $0.06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Milestone Scientific Reports 34% Increase in Revenue for the Second Quarter of 2016
August 12, 2016 7:14 AM EDTLIVINGSTON, NJ -- (Marketwired) -- 08/12/16 -- Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results for the second quarter ending June 30, 2016.
Leonard Osser, Chief Executive Officer of Milestone Scientific stated, "We have seen another consecutive quarter of solid revenue growth in our dental segment, reflecting the impact of our recent sales and... More
